IntroductionPolygenic risk scores (PRSs) have great clinical potential for detecting late-onset diseases such as Alzheimer's disease (AD), allowing the identification of those most at risk years before the symptoms present. Although many studies use various and complicated machine learning algorithms to determine the best discriminatory values for PRSs, few studies look at the commonality of the Single Nucleotide Polymorphisms (SNPs) utilized in these models.MethodsThis investigation focussed on identifying SNPs that tag blocks of linkage disequilibrium across the genome, allowing for a generalized PRS model across cohorts and genotyping panels. PRS modeling was conducted on five AD development cohorts, with the best discriminatory models e...
The identification of subjects at high risk for Alzheimer's disease is important for prognosis and e...
Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with p...
Objective To identify single-nucleotide polymorphisms (SNPs) associated with risk and age at onset ...
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clini...
Objective: Genome‐wide association studies (GWAS) have identified over 30 susceptibility loci assoc...
Sporadic early onset Alzheimer’s disease (sEOAD) exhibits the symptoms of late onset Alzheimer’s dis...
BackgroundIdentifying individuals at risk for developing Alzheimer disease (AD) is of utmost importa...
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with p...
Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individ...
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with p...
The identification of subjects at high risk for Alzheimer's disease is important for prognosis and e...
Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with p...
Objective To identify single-nucleotide polymorphisms (SNPs) associated with risk and age at onset ...
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clini...
Objective: Genome‐wide association studies (GWAS) have identified over 30 susceptibility loci assoc...
Sporadic early onset Alzheimer’s disease (sEOAD) exhibits the symptoms of late onset Alzheimer’s dis...
BackgroundIdentifying individuals at risk for developing Alzheimer disease (AD) is of utmost importa...
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with p...
Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individ...
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with p...
The identification of subjects at high risk for Alzheimer's disease is important for prognosis and e...
Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with p...
Objective To identify single-nucleotide polymorphisms (SNPs) associated with risk and age at onset ...